BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2799766)

  • 21. Desmopressin (DDAVP) enhances platelet adhesion to the extracellular matrix of cultured human endothelial cells through increased expression of tissue factor.
    Gálvez A; Gómez-Ortiz G; Díaz-Ricart M; Escolar G; González-Sarmiento R; Zurbano MJ; Ordinas A; Castillo R
    Thromb Haemost; 1997 May; 77(5):975-80. PubMed ID: 9184413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Desmopressin (DDAVP) for treatment of disorders of hemostasis.
    Mannucci PM
    Prog Hemost Thromb; 1986; 8():19-45. PubMed ID: 3104987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of desmopressin to prevent bleeding in surgery.
    Flordal PA
    Eur J Surg; 1998 Jan; 164(1):5-11. PubMed ID: 9537702
    [No Abstract]   [Full Text] [Related]  

  • 24. Platelet-serotonin in uraemia.
    Kamoun P; Kleinknecht D; Ducrot H; Jerome H
    Lancet; 1970 Apr; 1(7650):782. PubMed ID: 4191285
    [No Abstract]   [Full Text] [Related]  

  • 25. [Serotonin levels in the blood of patients with terminal renal failure].
    Myśliwiec M; Tomasiak M; Pytel B; Soszka J
    Pol Tyg Lek; 1986 Jan; 41(2):35-7. PubMed ID: 3703722
    [No Abstract]   [Full Text] [Related]  

  • 26. [The serotonin content in human platelets is unstable: data and possible mechanisms].
    Karas' SI; Iazykov KG; Makarova EV; Danilets AV
    Biull Eksp Biol Med; 1993 Mar; 115(3):249-51. PubMed ID: 8054608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Studies on platelet aggregation and 14C-serotonin release in patients with uremia].
    Kang ZQ; Wang Z; Cui W; Li W
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1985 Dec; 7(6):429-33. PubMed ID: 3011296
    [No Abstract]   [Full Text] [Related]  

  • 28. Retention test Homburg to monitor the adhesive properties of von Willebrand factor after substitution or desmopressin therapy.
    Wieding JU; Matern J; Köstering H; Wermes C; Wenzel E
    Semin Thromb Hemost; 2005; 31(4):441-8. PubMed ID: 16149022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pre-treatment of porcine pulmonary xenograft with desmopressin: a novel strategy to attenuate platelet activation and systemic intravascular coagulation in an ex-vivo model of swine-to-human pulmonary xenotransplantation.
    Kim YT; Lee HJ; Lee SW; Kim JY; Wi HC; Park SJ; Bae SJ; Kang HJ
    Xenotransplantation; 2008 Feb; 15(1):27-35. PubMed ID: 18333911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of acetaldehyde on some serotonergic mechanisms in rat blood platelets.
    Pawlak D; Chabielska E; Buczko W
    Pol J Pharmacol; 1993; 45(1):59-66. PubMed ID: 8401760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet aggregation at high shear is impaired in patients with congenital defects of platelet secretion and is corrected by DDAVP: correlation with the bleeding time.
    Cattaneo M; Pareti FI; Zighetti M; Lecchi A; Lombardi R; Mannucci PM
    J Lab Clin Med; 1995 Apr; 125(4):540-7. PubMed ID: 7706911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of desmopressin acetate to reduce blood transfusion requirements during cardiac surgery in patients with acetylsalicylic-acid-induced platelet dysfunction.
    Sheridan DP; Card RT; Pinilla JC; Harding SM; Thomson DJ; Gauthier L; Drotar D
    Can J Surg; 1994 Feb; 37(1):33-6. PubMed ID: 8306217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of desmopressin as a hemostatic agent: a concise review.
    Franchini M
    Am J Hematol; 2007 Aug; 82(8):731-5. PubMed ID: 17492648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Desmopressin: a new drug for the treatment of bleeding disorders.
    Haas D; Nace GS
    J Nephrol Nurs; 1985; 2(2):72-3. PubMed ID: 3845983
    [No Abstract]   [Full Text] [Related]  

  • 35. Shortening of bleeding time by 1-deamino-8-arginine vasopressin (DDAVP) in the absence of platelet von Willebrand factor in Gray platelet syndrome.
    Pfueller SL; Howard MA; White JG; Menon C; Berry EW
    Thromb Haemost; 1987 Dec; 58(4):1060-3. PubMed ID: 3502198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [DDAVP (desmopressin or Minirin)].
    Sultan Y
    Rev Prat; 1988 Jun; 38(18):1197. PubMed ID: 3175486
    [No Abstract]   [Full Text] [Related]  

  • 37. No influence of blood group on the responsiveness to desmopressin in type I "platelet normal" von Willebrand's disease.
    Castaman G; Rodeghiero F
    Thromb Haemost; 1995 Mar; 73(3):551-2. PubMed ID: 7667843
    [No Abstract]   [Full Text] [Related]  

  • 38. Discrepancy in fibrinolytic response to desmopressin as compared to venous occlusion--a preliminary report.
    Nilsen DW; Andersen P; Hjermann I; Godal HC
    Thromb Haemost; 1985 Feb; 53(1):160. PubMed ID: 3992517
    [No Abstract]   [Full Text] [Related]  

  • 39. Desmopressin and hemostasis.
    David JL
    Regul Pept; 1993 Apr; 45(1-2):311-7. PubMed ID: 8511363
    [No Abstract]   [Full Text] [Related]  

  • 40. Defective ADP-induced platelet factor 3 activation in uremia.
    Horowitz HI; Cohen BD; Martinez P; Papayoanou MF
    Blood; 1967 Sep; 30(3):331-40. PubMed ID: 6038305
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.